Search results for "Option"

showing 10 items of 345 documents

Transarterial radioembolization for hepatocellular carcinoma: a review

2016

Rodolfo Sacco,1 Caterina Conte,2 Emanuele Tumino,1 Giuseppe Parisi,1 Sara Marceglia,3 Salvatore Metrangolo,1 Roberto Eggenhoffner,4 Giampaolo Bresci,1 Giuseppe Cabibbo,5 Luca Giacomelli4 1Department of Gastroenterology, Cisanello Hospital, Pisa, 2Endocrinology and Metabolic Diseases, Policlinico A. Gemelli, Università Cattolica del Sacro Cuore, Rome, 3Department of Engineering and Architecture, University of Trieste, Trieste, 4Department of Surgical Sciences and Integrated Diagnostics, School of Medicine, Genova University, Genoa, 5Section of Gastroenterology, DIBIMIS, University of Palermo, Palermo, Italy Abstract: Hepatocellular carcinoma (HCC) is the most common type of liver canc…

Oncologymedicine.medical_specialtyReviewTransarterial RadioembolizationMalignancylcsh:RC254-28203 medical and health sciences0302 clinical medicineInternal medicineMedicineTherapeutic strategyCause of deathbusiness.industryTreatment optionshepatocellular carcinomahepatocellular carcinoma; transarterial radioembolizationmedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensdigestive system diseasesSafety profile030220 oncology & carcinogenesisHepatocellular carcinomatransarterial radioembolization030211 gastroenterology & hepatologybusinessLiver cancerhepatocellular carcinoma transarterial radioembolization
researchProduct

Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?

2014

Introduction: Treatment of ovarian cancer has been long standardized with the inclusion of surgery and chemotherapy based on platinum and taxanes, this strategy reaching high remission rates. However, when this treatment fails, further options are available with little benefit. Since ovarian cancer has specific immunologic features, actually immunotherapy is under evalua- 15 tion to overcome treatment failure in patients experiencing recurrence. Areas covered: Immunogenicity of ovarian cancer and its relationship with clinical outcomes is briefly reviewed. The kinds of immunotherapeutic strategies are summarized. The clinical trials investigating immunotherapy in recurrent ovarian cancer pa…

Oncologymedicine.medical_specialtySettore MED/06 - Oncologia Medicamedicine.medical_treatmentClinical BiochemistryTreatment failureInternal medicineDrug DiscoverymedicineAnimalsHumansIn patientTreatment FailureBiologyOvarian Neoplasmsantibody cancer vaccines cell transfer immune system immunotherapy ovarian cancer recurrence treatment strategiesPharmacologyChemotherapybusiness.industryTreatment optionsImmunotherapymedicine.diseaseClinical trialRecurrent Ovarian CancerImmunologyFemaleImmunotherapyHuman medicineNeoplasm Recurrence LocalOvarian cancerbusinessEngineering sciences. TechnologyExpert Opinion on Biological Therapy
researchProduct

Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?

2012

Mantle Cell Lymphoma (MCL) is associated with a dismal prognosis. Recently, along with the improved understanding of the pathophysiology of this disease, new first line regimens have been established and in addition novel treatment options have entered the clinical arena. In consequence, prognosis of the disease has fortunately improved. We here focus on the rationale, current clinical knowledge and future concepts of Temsirolimus, an inhibitor of mTOR, in the treatment of MCL. At this time this drug has been shown to be effective as single agent for relapsed disease and early combination data show promising results. In addition, with a brief outline of other treatment options, we aim to g…

Oncologymedicine.medical_specialtybusiness.industryFirst linemantle cell lymphomaCancerTreatment optionsmTOR-inhibitorReviewDiseasemedicine.diseaseBioinformaticslcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282TemsirolimusClinical knowledgeOncologyInternal medicinetemsirolimusmedicineRefractory Mantle Cell LymphomaMantle cell lymphomabusinessmedicine.drugClinical Medicine Insights: Oncology
researchProduct

Real Options Analysis (ROA)opens innovation: the biopharmaceutical case

2012

Open Innovation Real Options Analysis R&D Portfolio Biopharmacuetical industry
researchProduct

An user friendly Real Options based Model to Optimize Pharmaceutical R&D Portfolio

2013

Pharmaceutical industry pays great attention to its R&D process because it is a long, dynamic, very expensive, and uncertain process. On the other hand this process can be modelled as a step-wise process and each stage allows to achieve better information and generally lower uncertainty. In order to build up the best portfolio a tool able to capture the intrinsic flexible nature of the process should be selected: real options analysis has this characteristic but as widely demonstrated in literature, is narrowed to very limited cases because its perceived complexity. Basing on OptFolio, a model available in literature, this paper proposes an user friendly programming model based on Real Opti…

OptimizationR&D ManagementPortfolio SelectionSettore ING-IND/35 - Ingegneria Economico-GestionaleReal Options
researchProduct

The CDIO Syllabus 3.0 - An Updated Statement of Goals

2022

The CDIO Initiative is going through a process of reconsidering and updating the CDIO approach for engineering education development. Previous work resulted in substantial updates of the twelve CDIO standards and the introduction of “optional” CDIO standards. This paper reports on a similar review and update of the CDIO Syllabus to version 3.0. It has been developed by a working group consisting of four sub-groups and iterated and refined guided by feedback from the whole CDIO community. There are mainly three external drivers that 18 Proceedings of the 18th International CDIO Conference, hosted by Reykjavik University, Reykjavik Iceland, June 13-15, 2022. motivate the changes: sustainabili…

Optional standardstietoyhteiskuntaOther Engineering and Technologies not elsewhere specifiedAccelerationStandards 1-12acceleration Standards 1-12optional standardsustainabilitydigitalizationkorkeakouluopetustavoitteetinsinööritaitoCDIO SyllabuskoulutussuunnitteluteknologiaÖvrig annan teknikkestävyystyöelämädigitalisaatioopetussuunnitelmat
researchProduct

El efecto del anuncio de beneficios cuando cotizan opciones: un estudio conjunto del mercado de contado y el mercado de opciones

2015

ResumenEl objetivo del trabajo es comprobar, para los mercados de valores españoles, si el comportamiento de los precios incorporando la información revelada por el anuncio de beneficios trimestrales, es más eficiente en aquellas empresas en las cuales se negocian opciones sobre sus acciones. Utilizando la tradicional metodología del suceso y la comparación de funciones de distribución, obtenemos que para las empresas con opciones, la información se incorpora antes. Además, verificamos que hay un comportamiento anormal en el mercado de opciones que viene explicado por la información que contiene el beneficio. Los resultados obtenidos soportan la mejora de la eficiencia del mercado de contad…

Organizational Behavior and Human Resource ManagementEarningsFinancial economicsWelfare economicsStudy methodologyMercado de opcionesEquity (finance)Earnings announcementEfficiencyPrice discoveryEficienciaOrder (exchange)Price discovery processEconomicsPrice efficiencyOption marketStock marketListing (finance)Business and International ManagementAnuncios de beneficiosProceso de formación de preciosRevista Europea de Dirección y Economía de la Empresa
researchProduct

A skeletal Class III malocclusion with agenesis and canine-bicuspid transposition: a nonsurgical approach

2021

Abstract Background The present case report describes the orthodontic management of a patient who presented with a skeletal Class III malocclusion combined with other dental anomalies. The malocclusion was complicated by agenic maxillary lateral incisors and a lower right second premolar, in company with the transposition of the maxillary canines and premolars. Methods Dentoalveolar compensation of the anteroposterior jaw relationship was performed. The upper deciduous lateral incisors were extracted and the spaces closed, so that the first premolars replaced the missing lateral incisors while the canine transposition was maintained Results Satisfactory results were obtained which provided …

OrthodonticsDental anomaliesSurgical approachbusiness.industryTreatment optionsOrthodonticsSkeletal classmedicine.diseaseTransposition (music)medicine.anatomical_structureAgenesisDentistry Oral Surgery & MedicinePremolarMedicineMalocclusionbusinessAustralasian Orthodontic Journal
researchProduct

Treatment of Class III malocclusion using Hybrid Hyrax, Face Mask and Alt-RAMEC Protocol : a case report in a latin-american patient

2019

The management of Class III malocclusion is one of the greatest challenges of orthodontics. Current treatments offer the possibility of using direct skeletal anchorage to improve clinical outcomes. This case shows the results of using a Hyrax hybrid palatal anchorage, Alt-RAMEC (Alternate Rapid Maxillary Expansion and Contraction protocol) and a facemask to treat a maxillary hypoplasia Class III malocclusion in a Latin-American patient. The appliance design and the protocol used are widely described. Clinical and cephalometric results suggest that it is a good treatment option for this Latino patient, with moderate malocclusion and limitations in the dental anchorage. Key words:ALT-RAMEC, A…

OrthodonticsMaxillary hypoplasiaHyraxbiologybusiness.industryClass iii malocclusionTreatment optionsCase ReportOrthodontics030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseasebiology.organism_classification03 medical and health sciences0302 clinical medicineUNESCO::CIENCIAS MÉDICASmedicineRapid maxillary expansion030212 general & internal medicineMalocclusionbusinessGeneral DentistryAngle class iii
researchProduct

Italian multicentre study found infectious and vaccine-preventable diseases in children adopted from Africa and recommends prompt medical screening

2018

AIM This study evaluated the prevalence of infectious diseases and immunisation status of children adopted from Africa. METHODS We studied 762 African children referred to 11 Italian paediatric centres in 2009-2015. Clinical and laboratory data were retrospectively collected and analysed. RESULTS The median age of the children (60.3% males) was 3 years and 6 months, 52.6% came from Ethiopia and 50.1% had at least one infectious disease. Parasitic infections accounted for the majority of the infectious diseases (409 of 715), and the most common were Giardia lamblia (n = 239), Toxocara canis (n = 65) and skin infections (n = 205), notably Tinea capitis/corporis (n = 134) and Molluscum contagi…

Pediatricsmedicine.medical_specialtyTuberculosisEpidemiologyParasitic infectionsPopulationSkin infectionPediatricsQuantiFERON03 medical and health sciences0302 clinical medicine030225 pediatricsmedicineTuberculosis030212 general & internal medicineeducationeducation.field_of_studybusiness.industryEpidemiology; Immunisation; International adoption; Parasitic infections; Tuberculosis; Pediatrics Perinatology and Child HealthEpidemiology; Immunisation; International adoption; Parasitic infections; TuberculosisGeneral MedicinePerinatology and Child Healthmedicine.diseaseInternational adoptionVaccinationImmunisationSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAInfectious disease (medical specialty)Pediatrics Perinatology and Child HealthTinea capitisVaccine-preventable diseasesbusiness
researchProduct